We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 24 Jun 2021
Print article
Image: BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021 (Photo courtesy of Becton, Dickinson and Company)
Image: BD Demonstrates Latest Medtech Innovations at MEDLAB Middle East 2021 (Photo courtesy of Becton, Dickinson and Company)
Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) demonstrated its latest Medtech innovations at Medlab Middle East 2021 focusing on infection prevention and control, integrated diagnostics, and lab automation.

At this year’s Medlab Middle East, the company showcased its rapid diagnostic testing solutions to enable caregivers perform high number of tests in a short duration of time; advanced informatics and integrated diagnostics to enhance testing, automate workflows and help expedite decision-making; cutting-edge solutions for microbiology testing to facilitate rapid implementation of infection prevention and control measures; as well as microbiology automation amongst others. Experts from the BD team were also present at the company’s booth to host various in-depth sessions, share best practices, and demonstrate an array of innovative solutions to tackle the region’s ongoing healthcare challenges.

“Last year, the world was exposed to undesirable medical extremities,” said Maher Elhassan, Vice President & General Manager, BD Middle East, North Africa & Turkey. “Now is the time when communities in the region and throughout the world need our continued support and expertise to be able to fight all adversaries and recover. As part of our mission to advance the world of health, BD is determined to leave no stone unturned in our quest to impact people’s lives. Our participation at Medlab Middle East reiterates the company’s efforts to support the region’s healthcare sector with our latest innovations that deliver on patient care, safety, diagnostic accuracy, automation and more.”

Related Links:
Becton, Dickinson and Company

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
New
Chikungunya Rapid Test
Chikungunya IgG/IgM Rapid Test Kit
New
Urine Drug Test
Instant-view Buprenorphine Urine Drug Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Three newly identified protein biomarkers have the potential to improve diagnostic tools for colorectal cancer (Photo courtesy of Adobe Stock)

New Protein Biomarkers to Improve Diagnostic Tools for Colorectal Cancer

Colorectal cancer is a leading cause of cancer-related deaths globally, and its incidence is expected to rise in the coming decades. This cancer begins when abnormal cells grow uncontrollably in the large... Read more

Microbiology

view channel
Image: The CRISPR-TB Blood Test provides accurate, rapid, and cost-effective diagnosis (Photo courtesy of 123RF)

CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening

Tuberculosis (TB) continues to be a leading cause of global mortality, with 10.6 million new cases and 1.6 million deaths annually. Diagnosing TB remains difficult, with smear microscopy offering only... Read more

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.